Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
1.
Animals (Basel) ; 12(19)2022 Oct 09.
Article in English | MEDLINE | ID: mdl-36230453

ABSTRACT

Porcine epidemic diarrhea virus (PEDV) can cause severe infectious porcine epidemic diarrhea (PED) and infect different ages of pigs, resulting in sickness and death among suckling pigs. For PEDV detection, finding an effective and rapid method is a priority. In this study, we established an effective reverse transcription loop-mediated isothermal amplification (RT-LAMP) method for PEDV detection. Three sets of primers, specific for eight different sequences of the PEDV N gene, were designed in this study. The optimized RT-LAMP amplification program was as follows: 59 min at 61.9 °C and 3 min at 80 °C. The RT-LAMP results were confirmed with the addition of SYBR Green I fluorescence dye and with the detection of a ladder-like band by conventional gel electrophoresis analysis, which demonstrated a significant agreement between the two methods. The LOD of PEDV by RT-LAMP was 0.0001 ng/µL. Compared with RT-LAMP, the traditional RT-PCR method is 100-fold less sensitive. The RT-LAMP results had no cross-reaction with porcine parvovirus (PPV), porcine circovirus type 1 (PCV1), porcine pseudorabies virus (PRV), porcine circovirus type 2 (PCV2), rotavirus (RV), transmissible gastroenteritis virus (TGEV) and porcine reproductive and respiratory syndrome virus (PRRSV). Consequently, the newly developed RT-LAMP method could provide an accurate and reliable tool for PEDV diagnosis.

2.
Transbound Emerg Dis ; 68(3): 1454-1464, 2021 May.
Article in English | MEDLINE | ID: mdl-32857916

ABSTRACT

Pseudorabies virus (PRV), the causative agent of Aujeszky's disease, has resulted in substantial economic losses in the swine industry worldwide. Previous reports have shown that the PRV variant is responsible for the Pseudorabies outbreaks in Bartha-K61-vaccinated farms in China. However, there is limited information about the evolution of recombination of the PRV variant. Here, we isolated two PRV variants from a Bartha-K61-vaccinated swine farm, named them the JSY7 and JYS13 strains, analysed their complete genomic sequences and evaluated pathogenicity. As results, the JSY7 and JSY13 strains showed different cytopathic effects and plaque sizes. The JSY7 and JSY13 strains had the same Aspartate insertions in the gE protein as other PRV variants. The JSY7 and JSY13 strains were clustered into the same clade based on a genomic phylogenetic analysis. However, the JSY7 strain was relatively close to recent PRV isolates in China, while the JSY13 strain was more closely related to earlier PRV isolates. Interestingly, the gC gene phylogenetic tree showed that the JSY7 strain belonged to genotype II lineage 3, while the JSY13 strain belonged to genotype I and is the same branch with the Bartha strain. Furthermore, the PRV variants were relatively distant from the Bartha strain in the phylogenetic analysis of the gB, gC and gD genes. Importantly, a recombination analysis showed that the JSY13 strain might be a natural recombinant between the minor parental genotype I Bartha strain and the major parental genotype II JSY7 strain. Finally, we also found that the JSY13 strain showed a moderate virulence compared to the JSY7 strain in mice. Taken together, our data provide direct evidence for genomic recombination of PRV in nature, which may play an important role in the evolution and virulence of PRV. This discovery suggests that live PRV vaccine can act as genetic donors for genomic recombination.


Subject(s)
Genome, Viral , Herpesvirus 1, Suid/genetics , Herpesvirus 1, Suid/pathogenicity , Pseudorabies/virology , Swine Diseases/virology , Amino Acid Sequence , Animals , China , Phylogeny , Pseudorabies Vaccines/genetics , Sequence Alignment , Swine , Virulence
3.
J Virol ; 94(21)2020 10 14.
Article in English | MEDLINE | ID: mdl-32796073

ABSTRACT

Japanese encephalitis virus (JEV) is a viral zoonosis that can cause viral encephalitis, death, and disability. Although the Culex mosquito is the primary vector of JEV, little is known about JEV transmission by this kind of mosquito. Here, we found that mosquito defensin facilitated the adsorption of JEV on target cells via the defensin/lipoprotein receptor-related protein 2 (LRP2) axis. Mosquito defensin bound the ED III domain of the viral envelope (E) protein and directly mediated efficient virus adsorption on the target cell surface; the receptor LRP2, which is expressed on the cell surface, affected defensin-dependent adsorption. As a result, mosquito defensin enhanced JEV infection in the salivary gland, increasing the possibility of viral transmission by mosquitoes. These findings demonstrate the novel role of mosquito defensin in JEV infection and the mechanisms through which the virus exploits mosquito defensin for infection and transmission.IMPORTANCE In this study, we observed the complex roles of mosquito defensin in JEV infection; mosquito defensin exhibited a weak antiviral effect but strongly enhanced binding. In the latter, defensin directly binds the ED III domain of the viral E protein and promotes the adsorption of JEV to target cells by interacting with lipoprotein receptor-related protein 2 (LRP2), thus accelerating virus entry. Together, our results indicate that mosquito defensin plays an important role in facilitating JEV infection and potential transmission.


Subject(s)
Culex/genetics , Defensins/genetics , Encephalitis Virus, Japanese/genetics , Insect Proteins/genetics , Low Density Lipoprotein Receptor-Related Protein-2/genetics , Mosquito Vectors/genetics , Viral Envelope Proteins/genetics , Adsorption , Animals , Culex/virology , Defensins/metabolism , Encephalitis Virus, Japanese/metabolism , Encephalitis, Japanese/transmission , Encephalitis, Japanese/virology , Gene Expression Regulation , Host-Pathogen Interactions/genetics , Humans , Insect Proteins/metabolism , Low Density Lipoprotein Receptor-Related Protein-2/metabolism , Mosquito Vectors/virology , Protein Binding , Salivary Glands/metabolism , Salivary Glands/virology , Viral Envelope Proteins/metabolism , Virus Internalization
4.
Vet Microbiol ; 242: 108587, 2020 Mar.
Article in English | MEDLINE | ID: mdl-32122591

ABSTRACT

Japanese encephalitis virus (JEV) causes a serious zoonotic disease worldwide, pig is the reservoir and amplifying host of JEV. JEV can persist infect tonsil in pig, but the relation between persist infection in tonsil and reservoir are not clear until now. A stable pig tonsil cell line is necessary for JEV persist infection research. In this study, we established a continuous epithelial cell line, named PT cell, from the pig tonsil. This cell is susceptible to JEV. We determined the growth characteristics, molecular properties, microstructure profiles of PT cell. JEV is easy to enter PT cell which may partly explain the reason of persist infection. We further determined that LMAN2L, a mannose lectin proteins, is the primary viral receptors for JEV entry in PT cell. IFITM3, an cellular surface antiviral factor, is underexpression in PT cell after JEV infection. All these results provide solid evidence that PT cell will promote additional research on JEV persist infection in pig tonsil.


Subject(s)
Cell Line , Encephalitis Virus, Japanese/physiology , Palatine Tonsil/cytology , Palatine Tonsil/virology , Animals , Cell Culture Techniques , Cell Membrane , Encephalitis Virus, Japanese/genetics , Encephalitis Virus, Japanese/growth & development , Encephalitis, Japanese/virology , Swine , Virology/methods , Virus Internalization , Virus Replication
5.
Vet Microbiol ; 229: 28-38, 2019 Feb.
Article in English | MEDLINE | ID: mdl-30642596

ABSTRACT

Porcine reproductive and respiratory syndrome (PRRS) is an economically important disease with a significant impact on the pig industry. It is caused by PRRS virus (PRRSV), which predominantly infects and replicates in porcine pulmonary alveolar macrophages (PAMs). We pretreated PAMs with porcine interferon (IFN)-α to induce an antiviral state within the cells and subsequently infected them with highly pathogenic PRRSV. Changes in global gene expression in IFN-α-pretreated PAMs in response to PRRSV infection were determined by RNA-sequence analysis and confirmed by real-time PCR. We found that IRF7 and other antiviral interferon stimulating genes (ISG)s were suppressed by PRRSV infection. Further studies demonstrated that PRRSV could down-regulate the expression of IRF7 by the non-structure protein 7 (nsp7). In conclusion, PRRSV infection had a strong immunosuppressive effect of IFN. PRRSV nsp7 inhibits the expression of IRF7, thereby down-regulating the expression of IFN and downstream ISGs and facilitated the virus to replicate.


Subject(s)
Interferon Regulatory Factor-7/metabolism , Interferon-alpha/pharmacology , Macrophages/drug effects , Porcine respiratory and reproductive syndrome virus/physiology , Pulmonary Alveoli/cytology , Animals , Base Sequence , Cells, Cultured , Gene Expression Regulation/drug effects , Immunity, Cellular , Interferon Regulatory Factor-7/genetics , RNA/genetics , RNA/metabolism , Swine , Viral Nonstructural Proteins/genetics , Viral Nonstructural Proteins/metabolism
6.
Cytokine ; 110: 70-77, 2018 10.
Article in English | MEDLINE | ID: mdl-29704821

ABSTRACT

Japanese encephalitis (JE) is a viral encephalitis disease caused by infection with the Japanese encephalitis virus (JEV). The virus can cross the blood-brain barrier and cause death or long-term sequela in infected humans or animals. In this study, we first investigated the distribution of JEV infection in brain and further analyzed the dynamic change in inflammation related genes, chemokines, as well as pathological characteristics. Results demonstrated that CCR2 and CCR5 antagonist could significantly inhibit the inflammation. The mice treated with CCR2 and CCR5 antagonists had a higher survival rate between 60% and 70%, respectively. In summary, our study thoroughly illustrated the characteristics of the dynamic change in inflammation related genes and chemokines induced by JEV infection. We further indicated that CCR5 and CCR2 are potential targets for treatment of JE.


Subject(s)
CCR5 Receptor Antagonists/pharmacology , Chemokines/metabolism , Encephalitis, Japanese/drug therapy , Encephalitis, Japanese/metabolism , Inflammation/drug therapy , Inflammation/metabolism , Receptors, Chemokine/antagonists & inhibitors , Animals , Blood-Brain Barrier/metabolism , Brain/drug effects , Brain/metabolism , Cell Line , Chlorocebus aethiops , Cytokines/metabolism , Disease Models, Animal , Encephalitis Virus, Japanese/drug effects , Female , Mice , Mice, Inbred C57BL , Receptors, CCR2/antagonists & inhibitors , Receptors, CCR5 , Vero Cells
7.
Res Vet Sci ; 113: 13-20, 2017 Aug.
Article in English | MEDLINE | ID: mdl-28818749

ABSTRACT

Porcine Reproductive and Respiratory Syndrome (PRRS), which is caused by Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) infection, has caused substantial economic losses for the global swine industry. To date, there are limited commercially available measures to control the spread of PRRSV. The available vaccines are unstable and there is no anti-PRRSV therapeutic available. Therefore, this study designed a novel recombinant antiviral protein that included a novel polypeptide that binds to the PRRSV polymerase (p9), the transduction ability of the HIV TAT, and the nucleotide degradation activity of interferon stimulated gene 20 (ISG20). The recombinant proteins TAT-p9-ISG20 and p9-ISG20 were expressed in MARC-145 cells by transient transfection and then tested for antiviral activity and entry efficiency. The p9-ISG20 construct had greater antiviral activity than either p9 alone (1.37-fold) or ISG20 alone (1.9-fold). Addition of the HIV TAT protein increased the entry efficiency of p9-ISG20 by 1.57-fold, which was associated with increased anti-viral activity (1.52-fold) compared to P9-ISG20. In summary, TAT-p9-ISG20 achieved a synergistic effect by combining three different antiviral proteins and may be a novel PRRSV therapeutic platform.


Subject(s)
Porcine Reproductive and Respiratory Syndrome/prevention & control , Porcine respiratory and reproductive syndrome virus/immunology , Viral Vaccines/pharmacology , Animals , Peptides/administration & dosage , Peptides/pharmacology , Recombinant Proteins/administration & dosage , Recombinant Proteins/pharmacology , Swine , Viral Vaccines/administration & dosage
8.
Antiviral Res ; 108: 56-64, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24942376

ABSTRACT

Japanese encephalitis virus, a serious mosquito-borne flavivirus, causes acute encephalitis in humans and many animals, with a high fatality rate. RNA interference is a reasonable antiviral mechanism for target gene silencing. In this study, four lentiviral shRNAs (LV-E1, LV-E2, LV-NS3 and LV-NS4b) were constructed. The results showed that four recombinant lentiviruses suppressed JEV replication in vitro. Through treatment with LV-E1 or LV-E2, the TCID50 values were reduced by 10(3)-fold during 120h post-challenge; the relative expression of viral mRNA was <7% or 13% in mouse and human neuroblastoma cells. Lentiviral shRNAs displayed robust inhibitory activity in various cells and against different genotypes of JEV. In vivo, pre-treatments of LV-E1 or LV-E2 resulted in no viral particles being observed in suckling mice brain sections. For 21days of observation, 100% of mice were protected against lethal JEV injection by two pre-treatments with LV-E1 or LV-E2; the survival of the mice pre-challenged with lethal JEV was 88.3%/66.7% by treatment with LV-E1 or LV-E2. LV-E1 and LV-E2 suppressed the induction of inflammatory mediators effectively in neuroblastoma cells and mice. Lentiviral shRNAs significantly inhibit JEV infection for long-term in vitro and in vivo and effectively reduce the inflammatory response and relieve encephalitis symptoms, highlighting the feasibility of using lentivirus-mediated RNAi for potential therapy in JEV infection.


Subject(s)
Antiviral Agents/administration & dosage , Encephalitis Virus, Japanese/physiology , Encephalitis, Japanese/virology , Lentivirus/genetics , RNA Interference , RNA, Viral/administration & dosage , Viral Interference , Animals , Antiviral Agents/pharmacology , Antiviral Agents/therapeutic use , Brain/pathology , Brain/virology , Disease Models, Animal , Encephalitis Virus, Japanese/genetics , Encephalitis, Japanese/drug therapy , Encephalitis, Japanese/pathology , Female , Inflammation/pathology , Mice, Inbred BALB C , RNA, Viral/pharmacology , RNA, Viral/therapeutic use , Survival Analysis , Viral Load , Virus Cultivation , Virus Replication
9.
Cryobiology ; 69(1): 110-8, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24930584

ABSTRACT

An ice nucleating protein (INP) coding region with 66% sequence identity to the INP of Pseudomonas syringae was previously cloned from P. borealis, a plant beneficial soil bacterium. Ice nucleating activity (INA) in the P. borealis DL7 strain was highest after transfer of cultures to temperatures just above freezing. The corresponding INP coding sequence (inaPb or ina) was used to construct recombinant plasmids, with recombinant expression visualized using a green fluorescent protein marker (gfp encoding GFP). Although the P. borealis strain was originally isolated by ice-affinity, bacterial cultures with membrane-associated INP-GFP did not adsorb to pre-formed ice. Employment of a shuttle vector allowed expression of ina-gfp in both Escherichia coli and Pseudomonas cells. At 27 °C, diffuse fluorescence appeared throughout the cells and was associated with low INA. However, after transfer of cultures to 4 °C, the protein localized to the poles coincident with high INA. Transformants with truncated INP sequences ligated to either gfp, or an antifreeze protein-gfp fusion showed that the repetitive ice-nucleation domain was not necessary for localization. Such localization is consistent with the flanking residues of the INP associating with a temperature-dependent secretion apparatus. A polar location would facilitate INP-INP interactions resulting in the formation of larger aggregates, serving to increase INA. Expression of INPs by P. borealis could function as an efficient atmospheric dispersal mechanism for these soil bacteria, which are less likely to use these proteins for nutrient procurement, as has been suggested for P. syringae.


Subject(s)
Bacterial Outer Membrane Proteins/biosynthesis , Bacterial Proteins/biosynthesis , Pseudomonas/genetics , Pseudomonas/metabolism , Bacterial Outer Membrane Proteins/genetics , Bacterial Proteins/genetics , Cloning, Molecular , Escherichia coli/genetics , Escherichia coli/metabolism , Freezing , Green Fluorescent Proteins/genetics , Plasmids/genetics , Recombinant Fusion Proteins/biosynthesis , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Soil Microbiology
10.
Virology ; 454-455: 48-59, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24725931

ABSTRACT

Japanese encephalitis virus (JEV) is a serious mosquito-borne flavivirus that causes acute encephalitis in humans and many animals, with a high fatality rate. RNA interference (RNAi) is an evolutionarily conserved mechanism for the specific suppression of gene expression, which can be used as a reasonable antiviral strategy. In this study, 10 shRNAs targeting different regions of the JEV genome were designed, and their inhibition of viral replication in vitro and in vivo was determined. Treatment with these shRNAs significantly inhibited JEV replication in BHK-21 and SK-N-SH cells. An immunohistochemical analysis of suckling mice showed that brain sections pretreated with pGP-JE-1, pGP-JE-2 or pGP-JE-3 lacked viral particles. The survival of BALB/c mice challenged with 20 LD50 of the JEV NJ2008 strain at 24h post-injection or simultaneously with pGP-JE-2 was 83.3% and 66.7%, respectively. The results demonstrated that the efficiency of gene silencing and virus inhibition varied between shRNAs to different target genes and sites. Meanwhile, the shRNA-mediated antiviral effect was dose- and time-dependent, including prophylactic and therapeutic effect on virus infection both in vitro and in vivo. The whole results indicate that these shRNAs can inhibit JEV infection sufficiently in vitro and in vivo and might be a potential new tool for controlling JEV infection.


Subject(s)
Antiviral Agents/metabolism , Biological Products/metabolism , Encephalitis Virus, Japanese/drug effects , RNA Interference , RNA, Small Interfering/metabolism , Virus Replication/drug effects , Animals , Antiviral Agents/therapeutic use , Biological Products/therapeutic use , Cell Line , Cricetinae , Disease Models, Animal , Encephalitis Virus, Japanese/physiology , Encephalitis, Japanese/prevention & control , Female , Humans , Mice , Mice, Inbred BALB C , Microbial Sensitivity Tests , RNA, Small Interfering/therapeutic use , Survival Analysis , Treatment Outcome
11.
Res Vet Sci ; 95(3): 950-6, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24012350

ABSTRACT

Japanese encephalitis virus (JEV) causes serious zoonosis in South Asia, Southeast Asia and other areas. Pigs are an important reservoir for this virus in nature. The treatment of JEV infection in pigs is important for controlling the prevalence of JEV in humans and economic losses in pig farming. In this study, we selected a high activity porcine alpha-interferon to inhibit JEV replication in porcine kidney cell lines (PK-15). Alpha interferon exhibited high antiviral activity against JEV; the expression of three interferon-stimulated genes (ISGs), ISG15, Mx2 and OAS L, increased significantly after interferon treatment. Furthermore, we verified the anti-JEV effect of these ISGs by RNAi and overexpression. Mx2 and OAS L exhibited strong anti-JEV effects in PK-15 cells. Based on these novel results, alpha interferon (IFN-α) should be considered to be a potential drug against JEV in pigs.


Subject(s)
Encephalitis Virus, Japanese/physiology , Interferon Regulatory Factors/metabolism , Interferon-alpha/pharmacology , Virus Replication/drug effects , Animals , Cell Line , Dose-Response Relationship, Drug , Encephalitis Virus, Japanese/drug effects , In Vitro Techniques , Interferon Regulatory Factors/physiology , Kidney/cytology , Kidney/virology , Real-Time Polymerase Chain Reaction/veterinary , Swine
12.
Vaccine ; 31(11): 1535-9, 2013 Mar 01.
Article in English | MEDLINE | ID: mdl-23000123

ABSTRACT

The bursa of Fabricius is critical for the normal development of the B lymphocytes responsible for antibody production. However, the mechanism of the bursal-derived bioactive factor on B cell development is little reported. In this paper, chicks were immunized with BPP-II and AIV vaccine or AIV antigen, and antibody and IL-4 production were detected. The results showed that BPP-II played strongly inducing roles on the humoral immune responses. To investigate the gene expression at transcriptional level, avian pre-B lymphocyte DT40 cells were treated with BPP-II, and were analyzed with the gene microarray. The results proved that BPP-II treatment regulated 11 pathways, in which homologous recombination is a vital mechanism which is involved in antibody Ig gene conversion and diversification during B cell development. These results suggested Bursal-derived biological active factor BPP-II might be involved in the antibody production processes and B cell development, which is vital to the humoral central immune organ, the bursa of Fabricius.


Subject(s)
Antibody Formation , Interleukin-4/metabolism , Oligopeptides/immunology , Precursor Cells, B-Lymphoid/immunology , Animals , Chickens , Gene Expression Profiling , Influenza A Virus, H9N2 Subtype/immunology , Influenza Vaccines/immunology , Microarray Analysis
13.
Virology ; 432(1): 73-80, 2012 Oct 10.
Article in English | MEDLINE | ID: mdl-22743126

ABSTRACT

Porcine reproductive and respiratory syndrome is an important infectious disease of pigs and has a significant harmful effect on the livestock industry, especially in China. PRRSV ORF1b gene encodes primary proteins which play a vital role during PRRSV replication. In this paper, various 12-amino-acid peptides were displayed. These peptides could bind to the polymerase and helicase of PRRSV ORF1b protein, respectively, in which p9 exerted the highest antiviral activity with an IC50 of 56 µM, and the minimum toxicity to cells. It was proved that p9 inhibited PRRSV replication in infected MARC-145 cells in a dose-dependent manner, and the amino acid sequence of HRILMRIR was important for antiviral activity of p9. Also, p9 could bind to the cell membrane and penetrated into cells. These result suggested that p9 might be a potential therapeutic drug for PRRSV infection.


Subject(s)
Antiviral Agents/pharmacology , Peptides/pharmacology , Porcine respiratory and reproductive syndrome virus/drug effects , Viral Proteins/antagonists & inhibitors , Animals , Antiviral Agents/isolation & purification , Cell Line , China , Inhibitory Concentration 50 , Microbial Sensitivity Tests , Peptide Library , Peptides/isolation & purification , Swine , Viral Proteins/genetics
14.
Antiviral Res ; 74(1): 36-42, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17287033

ABSTRACT

Transmissible gastroenteritis virus (TGEV) is identified as one of the most important pathogenic agents during swine enteric infection, leading to high mortality in neonatal pigs and severe annual economic loss in swine-producing areas. Up to date, various vaccines developed against TGEV still need to be improved. To exploit the possibility of using RNA interference (RNAi) as a strategy against TGEV infection, two shRNA-expressing plasmids (pEGFP-U6/P1 and pEGFP-U6/P2) targeting the RNA-dependent RNA polymerase (RdRp) gene of TGEV were constructed and transfected into swine testicular (ST) cells. The cytopathic effect (CPE) and MTS assays demonstrated that both shRNAs were capable of protecting cells against TGEV invasion with very high specificity and efficiency. A real-time quantitative RT-PCR further confirmed that the amounts of viral RNAs in cell cultures pre-transfected with the two plasmids were reduced by 95.2% and up to 100%, respectively. Our results suggest that RNAi might be a promising new strategy against TGEV infection.


Subject(s)
Gastroenteritis, Transmissible, of Swine/virology , Genes, Viral , RNA Interference , RNA-Dependent RNA Polymerase/genetics , Transmissible gastroenteritis virus/physiology , Animals , Cell Line/virology , Gastroenteritis, Transmissible, of Swine/therapy , Plasmids , Sensitivity and Specificity , Swine , Transfection/methods , Virus Replication/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...